Skip to main content
Log in

Lumpectomy or mastectomy? Is breast conserving surgery too expensive?

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

In the last decade, breast cancer patients have enjoyed an increase inbreast conserving surgery (BCS). At present, modified radical mastectomy(MRM) and BCS offers equal expectations of survival. During the last fewyears, however, a drop in the frequency of BCS has been reported by severalauthors. Is this new trend due to economic concerns? To clarify the costs ofbreast cancer therapy (stage I and II), we review the literature and includea cost-utility and a cost-minimisation analysis comparing MRM and BCS.

The treatment cost (per patient) of BCS and MRM in Norway was calculated at$ 9,564 and $ 5,596, respectively. Employing a quality of lifegain in BCS of 0.03 (0–1 scale) and a 5% discount rate, thecost per QALY in BCS compared to MRM was $ 20,508. In cost-minimisinganalysis, BCS and mastectomy followed by reconstructive surgery had a costof $ 10,748 and $ 8,538, respectively. This indicates that BCSremains within reasonable cost and should not be displaced by mastectomy oneconomic grounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Munoz E. Shamash F, Friedman M, Teicher I, Wise L: Lumpectomy vs mastectomy. The cost of breast preservation for cancer. Arch Surg 121: 1297–1301, 1986

    Google Scholar 

  2. Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS: Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 326: 1102–1107, 1992

    Google Scholar 

  3. De Koning HJ, van Dongen JA, van der Maas PJ: Changes in use of breast-conserving therapy in years 1978–2000. Br J Cancer 70: 1165–1170, 1994

    Google Scholar 

  4. Norum J: Breast conserving surgery (BCS) in northern Norway. Multicenter cooperative studies and treatment protocols ensure a high treatment standard. Int J Oncol 8: 633–637, 1996

    Google Scholar 

  5. Tarbox BB, Rockwood JK, Abernathy CM: Are modified radical mastectomies done for T1 breast cancers because of surgeons advice or patients choice? Am J Surg 164: 417–422, 1992

    Google Scholar 

  6. Veronesi U, Saccozzi R, Del Vecchio M: Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. N Engl J Med 305: 6–10, 1981

    Google Scholar 

  7. Iglehart JD: Medicare begins prospective payment for hospitals. N Engl J Med 308: 1428–1432, 1983

    Google Scholar 

  8. The National Health Administration. The DRG system. Price list and codes for 1996. The National Health Administration, Oslo, 1996

    Google Scholar 

  9. Voogd AC, Repelaer van Driel OJ, Roumen RMH, Coebergh JWW: Changing attitudes among surgeons towards breast-conserving treatment of early breast cancer. EJC 1996, 32A,Suppl 2, 18

    Google Scholar 

  10. Muir C, Waterhouse J, McK T, Powell J, Whelan S: Cancer Incidence in Five Continents, Volume 5, International Agency for Research on Cancer, 1987

  11. Haakonsen K: The DRG-system employed at The Norwegian Radium Hospital. The Norwegian Radium Hospital, Oslo, 1996

    Google Scholar 

  12. Janjan NA, Murray KJ, Conway P, Walker A, Wilson F: Prognosis for breast cancer surgery and radiation therapy compared with mastectomy alone. A retrospective analysis of 759 patients with stage I/II breast cancer. Cancer 69: 2842–2848, 1992

    Google Scholar 

  13. The Norwegian Breast Cancer Group. Breast cancer, diagnosis and treatment. The Norwegian Cancer Union, Oslo, 1994

    Google Scholar 

  14. Zalcberg JR, Siderov J, Simes J: The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer. Ann Oncol 7: 41–46, 1996

    Google Scholar 

  15. Fowble B, Solin LJ, Schultz DJ et al.: Frequency, sites of relapse and outcome of regional node failure following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys 17: 703–710, 1989

    Google Scholar 

  16. Perez CA, Garcia DM, Kuske RR, Levitt SH: Breast, stage T1 and T2 tumours. In: Perez CA, Brady LW (eds) Principles and Practice of Radiation Oncology. Philadelphia, Lippincott, 877–947, 1992

    Google Scholar 

  17. Schwegler N, Kern T, Lazovic N, Notter M: Breast-preserving treatment of breast carcinoma. Analysis of surgical, pathologic-anatomic and radiotherapeutic data of 291 cases. Schweiz Rundsch Med Prax 85: 21–29, 1996

    Google Scholar 

  18. Giraud P, Vilcoq JR, Compana F, Clough L, Fourquet A: Long term time course of breast recurrence after breast-conservative treatment of small breast cancer. EJC 1996, 32A,Suppl 2, 21

    Google Scholar 

  19. Koopanchap MA, VanInevald BM: Towards a new approach for estimating indirect costs of disease. Soc Sci Med 34: 1005–1010, 1992

    Google Scholar 

  20. Norum J, Angelsen V, Wist E, Olsen JA: Treatment costs in Hodgkin's disease. A cost-utility analysis. Eur J Cancer 32: (in press), 1996

  21. Olsen JA: Production gains. Should they count in health care evaluations? Scotts J Political Econ 41: 69–84, 1994

    Google Scholar 

  22. Holmberg L, Omne-Pontèn M, Burns T, Adami HO, Bergstrøm R: Psychosocial adjustment after mastectomy and breast-conserving treatment. Cancer 64: 969–974, 1989

    Google Scholar 

  23. Lazovich D, White E, Thomas DB, Moe RE: Underutilization of breast-conserving surgery and radiation therapy among women with stage I and II breast cancer. JAMA 266: 3433–3438, 1991

    Google Scholar 

  24. Omne-Pontèn M, Holmberg L, Bergström R, Sjöden PO, Burns T: Psychosocial adjustment among husbands of women treated for breast cancer, mastectomy vs. breast-conserving surgery. Eur J Cancer 29: 1393–1397, 1993

    Google Scholar 

  25. Van Dongen JA, Bartelink H, Fentiman IS et al.: Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr 11: 15–18, 1992

    Google Scholar 

  26. Rauschecker HF, Sauer R, Schauer A, Schumacher M, Olschewski M, Sauerbrei W, Seegenschmiedt MH, Schmoor C: for the German Breast Cancer Study group. Therapy of small breast cancer — Four year results of a prospective non-randomized study. Breast Cancer Res Treat 34: 1–13, 1995

    Google Scholar 

  27. Fallowfield LJ, Hall A, Maguire GP, Baum M: Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ 301: 575–580, 1990

    Google Scholar 

  28. Bonnema J, van Geel AN, von Wersch A, Pruyn JFA, Wiggers T: A prospective randomized trial of short versus long hospital stay after surgery for breast cancer. EJC 1996, 32A,Suppl 2, 16

    Google Scholar 

  29. Williams A: EuroQol — a new facility for the measurement of health related quality of life. The EuroQol Group. Health Policy 16: 199–208, 1990

    Google Scholar 

  30. Epstein RJ: Does the breast dollar make sense? Eur J Cancer 28: 486–491, 1992

    Google Scholar 

  31. Blokhin SN, Portnoj SM, Lactinov KP, Barcanov AI, Coptiaeva IV, Blokhin NN: Immediate breast reconstruction (IBR) in breast cancer patients. EJC 1996, 32A,Suppl 2, 17

    Google Scholar 

  32. Demidov VP, Pak DD, Yermakov AV: Variants of immediate breast reconstruction in breast cancer treatment. EJC 1996, 32A,Suppl 2, 19

    Google Scholar 

  33. Galassi G, Amanti C, Regolo K, Lombardi A, Mauro G, Lucidsi M, DiPaolo M: Breast reconstruction following mastectomy. Our experience. EJC 1996, 32A,Suppl 2, 18

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Norum, J., Olsen, J.A. & Wist, E.A. Lumpectomy or mastectomy? Is breast conserving surgery too expensive?. Breast Cancer Res Treat 45, 07–14 (1997). https://doi.org/10.1023/A:1005804101106

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005804101106

Navigation